Carret Asset Management LLC Sells 150 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Carret Asset Management LLC trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBBGet Rating) by 3.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,828 shares of the financial services provider’s stock after selling 150 shares during the period. Carret Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $499,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Future Financial Wealth Managment LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $30,000. Gradient Investments LLC increased its position in shares of iShares Biotechnology ETF by 99.0% in the fourth quarter. Gradient Investments LLC now owns 201 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 100 shares during the last quarter. Consolidated Planning Corp bought a new position in shares of iShares Biotechnology ETF in the third quarter worth approximately $32,000. Steward Financial Group LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $34,000. Finally, Dixon Hughes Goodman Wealth Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $38,000. Institutional investors own 63.88% of the company’s stock.

Shares of NASDAQ IBB opened at $113.25 on Thursday. iShares Biotechnology ETF has a one year low of $104.29 and a one year high of $177.37. The firm’s 50 day simple moving average is $116.33 and its two-hundred day simple moving average is $128.58.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 15th. Shareholders of record on Friday, June 10th were given a dividend of $0.031 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.11%. The ex-dividend date of this dividend was Thursday, June 9th.

About iShares Biotechnology ETF (Get Rating)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Articles

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.